The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquila Euro. Regulatory News (AERI)

Share Price Information for Aquila Euro. (AERI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.70
Bid: 0.71
Ask: 0.738
Change: 0.01 (1.40%)
Spread: 0.028 (3.944%)
Open: 0.702
High: 0.702
Low: 0.70
Prev. Close: 0.714
AERI Live PriceLast checked at -
Aquila European Renewables Income is an Investment Trust

To generate stable returns, principally in the form of income distributions, by investing in a diversified portfolio of Renewable Energy Infrastructure Investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity & Total Voting Rights

7 Feb 2022 07:00

RNS Number : 8099A
Aquila European Renewables Income
07 February 2022
 

7 February 2022

Aquila European Renewables Income Fund plc

(the "Company")

 

Issue of Shares in connection with the payment of Investment Adviser fees

 

The Company announces that it has issued today 731,520 ordinary shares ("New Ordinary Shares") to Aquila Capital Investmentgesellschaft mbH, the Company's Investment Adviser, in relation to fees payable for the three-month period ended 31 December 2021. The New Ordinary Shares have been issued pursuant to the Investment Advisory Agreement ("IAA"), details of which were disclosed in the prospectus published by the Company on 17 September 2020.

 

The New Ordinary Shares are being issued at the latest prevailing adjusted Net Asset Value ('NAV')* as at 31 December 2021 of €1.0383 per Ordinary share.

 

Applications will be made for the New Ordinary Shares to be admitted to the premium segment of the Official List, and to trading on the London Stock Exchange's Main Market for listed securities ("Admission"). It is expected that Admission will become effective and dealings in the New Ordinary Shares will commence at 8am on 11 February 2022. The New Ordinary Shares will rank pari passu with the ordinary shares already in issue.

Following Admission, the Company's issued share capital will consist of 407,670,932 ordinary shares. Therefore, the total number of voting rights of the Company is 407,670,932 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or of a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

*the adjusted NAV is the NAV as at 31 December 2021 of €1.0258 plus the dividend of 1.25 cents paid during the period.

For further details contact:

Media contacts:Smithfield Consultants

Ged Brumby | 020 3047 2527

Kanayo Agwunobi | 020 3047 2126

Sponsor, Broker and Placing Agent

Numis Securities 020 7260 1000

Tod Davis

David Benda

Vicki Paine

 

Joint Financial Advisor

Kempen & Co +31 20 348 8000

Thomas ten Hoedt

Michiel Klomp

Robin van Wijk

 

 

NOTES

Aquila European Renewables Income Fund ("AERIF" or the "Company") is a recently established, London-listed renewable energy infrastructure investment company with the aim to provide investors with an attractive long-term, income-based return in EUR through a diversified portfolio of hydropower, onshore wind and solar PV investments across continental Europe and Ireland. Through the diversification of generation technologies, the seasonal production patterns of these asset types complete each other to balance the cash flow, while the geographic diversification serves to reduce exposure to one single energy market. AERIF is targeting an aggregate annual yield of 5.0% once fully invested.

Further details can be found on AERIF 's website at www.aquila-european-renewables-income-fund.com 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEBLGDDSBGDGDL
Date   Source Headline
5th Feb 20215:13 pmRNSIssue of Equity to Investment Adviser
5th Feb 20217:00 amRNSDividend Declaration
5th Feb 20217:00 amRNSNet Asset Value and Factsheet - 31 December 2020
30th Dec 20208:25 amRNSAquisition
23rd Dec 20204:04 pmRNSCompletion of Acquisition
4th Dec 20207:00 amRNSAcquisition
1st Dec 20207:00 amRNSTotal Voting Rights
5th Nov 20205:08 pmRNSIssue of Equity to Investment Adviser
5th Nov 20207:00 amRNSNet Asset Value and Factsheet - 30 September 2020
2nd Nov 20207:00 amRNSTotal Voting Rights
30th Oct 20207:00 amRNSInvestment Update
19th Oct 20204:48 pmRNSHolding(s) in Company
15th Oct 20203:26 pmRNSHolding(s) in Company
14th Oct 20205:20 pmRNSHolding(s) in Company
14th Oct 20205:09 pmRNSHolding(s) in Company
13th Oct 20205:21 pmRNSHolding(s) in Company
13th Oct 202012:50 pmRNSHolding(s) in Company
9th Oct 20207:00 amRNSIssue of Equity
6th Oct 202011:40 amRNSResult of General Meeting
30th Sep 20202:58 pmRNSDividend Declaration
17th Sep 202010:01 amRNSPublication of a Prospectus and Circular
15th Sep 20207:00 amRNSHalf-year Report
11th Sep 20208:51 amRNSAcquisition
2nd Sep 20203:04 pmRNSTotal Voting Rights
5th Aug 20203:50 pmRNSIssue of Equity to Investment Adviser
5th Aug 20207:02 amRNSIssue of Equity to Investment Adviser
5th Aug 20207:01 amRNSDividend Declaration
5th Aug 20207:00 amRNSNet Asset Value and Factsheet - 30 June 2020
31st Jul 20207:00 amRNSChange of Registered Office
8th Jun 20204:48 pmRNSResult of AGM
5th Jun 20204:19 pmRNSInvestment Update
13th May 20207:00 amRNSIssue of Equity to Investment Adviser
12th May 20207:02 amRNSNet Asset Value and Factsheet - 31 March 2020
12th May 20207:00 amRNSDividend Declaration
28th Apr 20207:00 amRNSFinal Results
2nd Apr 20202:59 pmRNSHolding(s) in Company
1st Apr 20206:18 pmRNSTotal Voting Rights
23rd Mar 20207:00 amRNSInvestment Update
11th Mar 20206:07 pmRNSHolding(s) in Company
11th Mar 20205:54 pmRNSHolding(s) in Company
9th Mar 20201:35 pmRNSHolding(s) in Company
6th Mar 20202:03 pmRNSIssue of Equity
5th Mar 20207:00 amRNSProposed Issue of Equity
11th Feb 202012:37 pmRNSIssue of Equity to Investment Adviser
11th Feb 202012:31 pmRNSNet Asset Value & Factsheet - 31 December 2019
11th Feb 202012:24 pmRNSDividend Declaration
22nd Jan 20204:46 pmRNSHolding(s) in Company
22nd Jan 20209:43 amRNSHolding(s) in Company
20th Jan 20203:08 pmRNSHolding(s) in Company
20th Dec 20194:50 pmRNSInvestment Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.